Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 41.19B | 41.58B | 41.78B | 35.71B | 33.08B | 30.74B |
Gross Profit | 6.29B | 6.20B | 6.25B | 5.50B | 5.03B | 4.74B |
EBITDA | 1.67B | 1.65B | 2.12B | 1.65B | 1.38B | 1.34B |
Net Income | 801.01M | 836.88M | 1.18B | 976.06M | 698.60M | 691.13M |
Balance Sheet | ||||||
Total Assets | 29.53B | 29.57B | 31.10B | 27.67B | 25.24B | 24.52B |
Cash, Cash Equivalents and Short-Term Investments | 4.24B | 3.08B | 4.20B | 2.75B | 2.30B | 1.95B |
Total Debt | 4.74B | 4.04B | 4.43B | 4.16B | 3.90B | 4.08B |
Total Liabilities | 14.98B | 14.72B | 16.91B | 14.11B | 12.50B | 12.05B |
Stockholders Equity | 14.55B | 14.85B | 14.19B | 13.56B | 12.74B | 12.48B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -390.24M | 1.56B | -230.73M | 992.65M | 806.46M |
Operating Cash Flow | 0.00 | 252.15M | 2.51B | 616.44M | 1.09B | 1.09B |
Investing Cash Flow | 0.00 | -641.80M | -662.83M | -192.78M | -78.45M | -570.66M |
Financing Cash Flow | 0.00 | -731.14M | -397.57M | 21.04M | -656.74M | -613.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €5.84B | 6.36 | 6.02% | 5.74% | -0.78% | -21.89% | |
80 Outperform | ¥13.65B | 7.70 | 3.00% | -1.59% | -6.38% | ||
79 Outperform | ¥9.15B | 5.18 | 3.55% | 10.44% | 46.04% | ||
78 Outperform | ¥38.08B | 14.95 | 0.83% | -15.98% | -51.13% | ||
76 Outperform | ¥67.56B | 9.88 | 3.38% | 7.56% | 12.07% | ||
72 Outperform | ¥27.10B | 6.35 | 7.91% | -10.85% | 25.59% | ||
63 Neutral | $34.16B | 5.78 | -11.85% | 1.82% | 5.31% | -18.32% |